KYOTO DRUG DISCOVERY & DEVELOPMENT
KDDD develop an innovative agent effective for various INCURABLE or INTRACTABLE eye diseases, especially CRAO, Retinal Pigmentosa, AMD and Glaucoma.
KYOTO DRUG DISCOVERY & DEVELOPMENT
Industry:
Health Care Product Research
Founded:
2015-05-15
Address:
Kyoto, Kyoto, Japan
Country:
Japan
Website Url:
http://www.kyoto-drug.com
Total Employee:
1+
Status:
Active
Contact:
(+81)75-761-2361
Total Funding:
972.8 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Euro Google Apps For Business SAKURA Internet ASAHINET DNS
Similar Organizations
Chenrui Health
Chenrui Health is a Healthcare company.
Healios
The UK’s leading digital healthcare company .
New Way Hemp
New Way Hemp is a Health Care Company.
Stork Healthcare
Stork Healthcare is a Healthcare Company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Seed Round - Kyoto Drug Discovery & Development
Miyako Capital
Miyako Capital investment in Seed Round - Kyoto Drug Discovery & Development
Osaka University Venture Capital
Osaka University Venture Capital investment in Seed Round - Kyoto Drug Discovery & Development
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Seed Round - Kyoto Drug Discovery & Development
Nissay Capital
Nissay Capital investment in Seed Round - Kyoto Drug Discovery & Development
Minato Capital
Minato Capital investment in Seed Round - Kyoto Drug Discovery & Development
SMBC Venture Capital
SMBC Venture Capital investment in Seed Round - Kyoto Drug Discovery & Development
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Seed Round - Kyoto Drug Discovery & Development
Official Site Inspections
http://www.kyoto-drug.com
- Host name: www1079.sakura.ne.jp
- IP address: 219.94.129.89
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "Kyoto Drug Discovery & Development"
Kyoto Drug Discovery & Development Co., Ltd.
April 28th. 2022 Kyoto Drug Discovery & Development successfully concludes a pre-IND meeting with FDA August 23rd. 2017 KDDD released this HP …See details»
Kyoto Drug Discovery & Development - Company Profile - Tracxn
Jun 14, 2025 Kyoto Drug Discovery & Development is a Japanese, early-stage biotech developing small molecule therapeutics for glaucoma and other degenerative eye diseases. …See details»
Kyoto Drug Discovery and Development - Crunchbase
Kyoto Drug Discovery and Development closed its last funding round on Feb 28, 2018 from a Seed round. Who are Kyoto Drug Discovery and Development 's …See details»
Kyoto Drug Discovery & Development - VentureRadar
KDDD (Kyoto Drug Discovery and Development Co., Ltd.) is a spin-off company from Kyoto University. Our project is based on a result of research by Department of Ophthalmology …See details»
#05 Nurturing university-based drug discovery seeds and relaying …
The company will use small molecule compounds developed at Kyoto University to develop new therapeutic agents for rare and intractable diseases in ophthalmology. The company expects …See details»
Kyoto Drug Discovery and Development Co.,Ltd
Kyoto Drug Discovery & Development Co., Ltd. (KDDD) is a clinical-stage biotech company originating from Kyoto University in Japan. Its lead compound, KUS121, is a novel …See details»
Kyoto Drug Discovery and Development Co., Ltd. | Reagan-Udall
Kyoto Drug Discovery and Development Co., Ltd. EA Therapies for Single Patient. Currently, we are not accepting requests. EA Policies for Single Patient. At this time, KDDD does not offer …See details»
Kyoto Drug Discovery & Development Co., Ltd. - Drug pipelines, …
May 7, 2025 Clinical Trials associated with Kyoto Drug Discovery & Development Co., Ltd. NCT06178055 / Active, not recruiting Phase 2. A Phase 2, Double-masked, Randomized, …See details»
Kyoto Drug Discovery & Development - Dealroom.co
May 1, 2015 Kyoto Drug Development and Discovery (KDDD) is a biopharmaceutical venture focused on developing innovative treatments for systemic diseases such as cancers and …See details»
株式会社 京都創薬研究所｜網膜中心動脈閉塞症・網膜 …
株式会社京都創薬研究所は、京都大学生命科学研究科(垣塚彰教授)、京都大学大学院医学研究科(吉村長久特命教授、前眼科学教授)および京都大学医学部附 …See details»
Kyoto Drug Discovery & Development Co., Ltd.
Kyoto Drug Discovery & Development: 10 Years of Progress. At Kyoto Drug Discovery & Development, we remain steadfast in our mission: to be a true …See details»
MIC : Kyoto University Graduate School of Medicine Medical …
Clinicians at the Kyoto University Hospital and basic medical scientists in Kyoto University School of Medicine join the projects and collaborate with the project PIs and company scientists. In …See details»
Kyoto Drug Discovery and Development - Crunchbase
Kyoto Drug Discovery and Development is funded by 7 investors. Mitsubishi UFJ Capital and Miyako Capital are the most recent investors. Which investors participated in the most funding …See details»
Drug Discovery Center | 京都大学大学院医学研究科医学研究支援 …
Drug Discovery Center. With support from the cutting-edge research infrastructure projects “Development of Cutting-Edge Drug Discovery Research and Educational Infrastructure …See details»
Kyoto Drug Discovery & Development Co., Ltd.
8F , DP Square Sakaisuji Honmachi 1-6-9 , Awaji-Machi , Chuo-ku , Osaka , 541-0047 JAPAN. Business hours : 10:00~19:00. Telephone:(+81)6-7777-1003See details»
Kyoto Pharmaceutical Industries, Ltd. | Corporate Website
Jan 5, 2017 Kyoto Pharmaceutical Industries focuses on research and development, which is the core of our founding spirit and our Corporate Identity itself. We have recruited excellent …See details»
Kyoto Drug Discovery and Development - Crunchbase
Kyoto Drug Discovery and Development has 6 board members and advisors, including Hanako Ikeda. Contacts. Edit Contacts Section. We're working on getting contact data for Kyoto Drug …See details»
株式会社 京都創薬研究所｜お知らせ - kyoto-drug.com
Apr 28, 2022 株式会社京都創薬研究所は、京都大学生命科学研究科(垣塚彰教授)、京都大学大学院医学研究科(吉村長久特命教授、前眼科学教授)および京都大学医学部附属病院臨床研究総 …See details»
UNODC World Drug Report 2025: Global instability compounding …
17 hours ago The cost of failing to tackle drug use disorders is steep – nearly half a million deaths and 28 million healthy years of life lost due to disability and premature deaths (DALY) …See details»
China group likely used Japan to ship fentanyl chemicals: Nikkei ...
1 day ago NEW YORK/MEXICO CITY/NAGOYA, Japan -- A Chinese organization allegedly used a base in Japan to smuggle chemicals to make the synthetic drug fentanyl into the U.S., …See details»